Harrow, Inc. reported $269M of revenue over the trailing twelve months, +26% on the year before. 10 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $269M (to Q1 2026). Net Income: −$15M, trailing twelve months to Q1 2026. Free Cash Flow: $14M, trailing twelve months to Q1 2026. Op Margin: 1.5%, trailing twelve months to Q1 2026.

HROWHarrow, Inc.

HealthcareUSD

$39.32

$29.0352 weeks$54.80

HROW as reported

Harrow, Inc. reported $269M of revenue over the trailing twelve months, +26% on the year before. 10 reported series are charted on this page, each one as filed.

$269M

Revenue, trailing twelve months · to Q1 2026 · +26% against the twelve months before

Net Income: −$15M
Net Income · −31% year on year · trailing twelve months to Q1 2026
Free Cash Flow: $14M
Free Cash Flow · +3295% year on year · trailing twelve months to Q1 2026
Op Margin: 1.5%
Op Margin · trailing twelve months to Q1 2026

Every series Ryufin has for HROW, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$269M	+26%	Q1 2026
Net Income	−$15M	−31%	Q1 2026
EPS	−$0.40	−34%	Q1 2026
Gross Margin	73%	n/a	Q1 2026
Op Margin	1.5%	n/a	Q1 2026
Net Margin	−11%	n/a	Q1 2026
ROE	−23%	n/a	Q1 2026
ROA	−2.3%	n/a	Q1 2026
ROIC	5.9%	n/a	Q1 2026
Free Cash Flow	$14M	+3295%	Q1 2026